Compare RGC & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | BETA |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.0B |
| IPO Year | 2021 | 2025 |
| Metric | RGC | BETA |
|---|---|---|
| Price | $17.59 | $30.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $39.00 |
| AVG Volume (30 Days) | 210.3K | ★ 882.4K |
| Earning Date | 10-24-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $28,920,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 88.32 |
| 52 Week Low | $0.09 | $22.40 |
| 52 Week High | $83.60 | $39.50 |
| Indicator | RGC | BETA |
|---|---|---|
| Relative Strength Index (RSI) | 64.34 | N/A |
| Support Level | $16.10 | N/A |
| Resistance Level | $17.40 | N/A |
| Average True Range (ATR) | 1.62 | 0.00 |
| MACD | 0.63 | 0.00 |
| Stochastic Oscillator | 88.24 | 0.00 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.